Yüklüyor......
Discovery of new biomarkers for malignant mesothelioma
Malignant mesothelioma is an asbestos-induced, aggressive tumour with limited treatment options and very poor outcome. Currently, there are no tumour biomarkers in widespread clinical use for this disease. Soluble mesothelin is the most intensively investigated mesothelioma biomarker and has been ap...
Kaydedildi:
| Yayımlandı: | Curr Pulmonol Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356891/ https://ncbi.nlm.nih.gov/pubmed/25927434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13665-015-0106-8 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|